PREMIERE
HIGHLIGHTS

Which symptoms impact your daily life with myasthenia gravis (MG)? Select all that apply.*

Which of these goals is most important to you or the person you know who has MG?*

I am a U.S. resident^‡ and I authorize argenx US Inc. ("argenx"), its affiliates and companies working with argenx to use my contact information and health information (“Information”) to contact me by direct mail, email, telephone and autodialed text message for marketing purposes, such as to provide me with information, offers and promotions regarding myasthenia gravis, argenx products and programs, to conduct market research or surveys, and to use my Information to develop future products, services and programs.

I understand that I may withdraw my authorization provided above by emailing privacy@argenx.com or following the unsubscribe instructions on the communication. Unless I withdraw this authorization, it will remain effective for 2 years. Copies of this authorization may be obtained by emailing privacy@argenx.com.

^‡Please be aware that this mailing list is intended for U.S. residents only. The processing of your personal data is regulated by local laws and requirements, which may not offer the same level of protection as those in your country of residency.

If you have a minute, please tell us a little more about yourself

Sharing this information will help us provide you with the most relevant MG updates, resources and information based on where you are in your MG journey and where you live in the country.

Filling out this information is optional and not required to receive MG United updates. You have already signed up for MG United.

*indicates required field

Which of these things best describes you?

I authorize argenx US Inc. ("argenx"), its affiliates and companies working with argenx to use my contact information and health information (“Information”) to contact me by direct mail, email, telephone and autodialed text message for marketing purposes, such as to provide me with information, offers and promotions regarding myasthenia gravis, argenx products and programs, to conduct market research or surveys, and to use my Information to develop future products, services and programs.

I understand that I may withdraw my authorization provided above by emailing privacy@argenx.com or following the unsubscribe instructions on the communication. Unless I withdraw this authorization, it will remain effective for 2 years. Copies of this authorization may be obtained by emailing privacy@argenx.com.